Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Tuesday, September 8, 2026

Snapshot: Sep 8, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Tue, Sep 8, 2026 Stock-Picker's Day High

Massive single-stock dispersion drowns out flat indices as healthcare bloodbath dominates losers while industrials and tech lead a fragmented gainer list.

60% A stock picker's paradise emerged with 50 gainers averaging +28.2% and 50 losers averaging -26.6%, yet the S&P 500 barely budged at -0.16%; Healthcare alone accounted for 44% of the top-50 losers, signaling a violent sector rotation with BPTH (+71%), ROC (+66%), and ZVZZT (+59%) soaring while ARCI crashed -95% and FCUV collapsed -68% on warrant dilution. The Russell 2000 inched up +0.13% while the Nasdaq Composite edged +0.19%, masking extreme dispersion beneath a calm headline.
25% Industrials dominated the gainers list with 28% share, outpacing tech's 22% and healthcare's 22%, signaling a subtle rotation away from mega-cap names into value and mid-market names; five tickers including KPLT (4-day streak), BPTH, and CUEN extended multi-day rallies while five debutants (OLB, OCTO, ATNM, ROIV, SEI) returned to favor after long absences, suggesting retail interest cycles through lower-liquidity names.
15% News-grounded catalysts anchored only a handful of moves—NMPAR surged 56% on the Gibson Technical Services business combination, PDSB jumped 40% on Dr. Soon-Shiong's board seat and $22.5M financing, and TTAN crashed 28% despite beating earnings due to weak Q3 guidance—while 70%+ of movers traded on technical factors, short-covering, or insufficient data, reflecting a market driven by algorithm and momentum rather than fundamentals.

Healthcare drove 44% of losers 5 names returned after long absences KPLT · 4-day gainers streak BPTH · 3-day gainers streak OLB — first appearance OCTO — first appearance

Market Regime

Tue, Sep 8, 2026 Neutral conf: medium macro · prototype

+13

Neutral −100 … +100 · + tailwind / − headwind

VIX15.7 p27 Drawdown-1.6% Held2d · nascent SinceSep 7

Top drivers: VIX percentile ▲ S&P drawdown (60d) ▲ Small-cap leadership ▼

processId: history-market-regime

Market Indexes

Tue, Sep 8, 2026 13

S&P 500

7,673.52

−12.62

-0.16%

Dow Jones

52,786.07

−399.83

-0.75%

NASDAQ Composite

26,421.41

+50.52

+0.19%

NASDAQ 100

29,507.70

+50.73

+0.17%

DJ US Total Market

75,896.07

−119.23

-0.16%

Russell 1000

4,178.83

−8.40

-0.20%

S&P MidCap 400

3,758.89

−1.35

-0.04%

Russell 2000

2,960.20

+3.75

+0.13%

Russell 2500

1,262.31

−8.41

-0.66%

Russell 3000

4,360.42

−8.19

-0.19%

Nasdaq Financial-100

7,702.31

−143.48

-1.83%

NIFTY 50

23,635.10

−279.35

-1.17%

VIX

15.72

+0.52

+3.42%

Biggest Gainers

Tue, Sep 8, 2026 50

BPTH

Bio-Path Holdings Inc

$0.03+$0.01

+71.3%

ROC

ROC Energy Acquisition Corp.

$4.40+$1.75

+66.0%

NASDAQ · Mkt cap $83 M

No news headlines were published about ROC in the last 48 hours, so the 66% gain likely stems from a corporate event, rumor, or technical catalyst not yet reflected in major news feeds or a delayed market reaction to an earlier announcement.

ROC Energy Acquisition Corp. is a SPAC (Special Purpose Acquisition Company), a structure that can experience sharp price moves on relatively thin volumes when merger announcements, regulatory approvals, or business combination developments occur. The absence of news in the Yahoo Finance RSS feed does not mean no catalyst occurred; news may have been released through press release channels, SEC filings, or company websites without yet appearing in syndicated feeds, or the move may reflect resolution of a previously announced deal contingency. SPACs are also prone to technical rallies when options activity, short squeezes, or retail interest surge around key milestones. Without access to SEC filings, press releases, or intraday volume data, the specific driver cannot be pinpointed.

ZVZZT

$18.05+$6.72

+59.3%

INDP

Indaptus Therapeutics, Inc.Healthcare

$1.84+$0.66

+58.1%

NASDAQ · Mkt cap $125 M

No news headlines were found in the last 48 hours for INDP, so the 58% jump on September 8 cannot be attributed to a disclosed catalyst. The move likely reflects either a delayed reaction to an earlier announcement, short-covering, or undisclosed rumors.

Indaptus Therapeutics is a small-cap biopharmaceutical company, and a 58% single-day surge with zero recent news coverage is typical behavior for illiquid micro-cap stocks that are prone to technical rallies and short squeezes. Without any earnings, FDA action, clinical trial update, partnership announcement, or guidance change documented in the provided headlines, the move cannot be grounded in fundamental news. Possible explanations include: (1) a short squeeze or technical breakout that occurred organically on low volume, (2) a press release or company announcement that was issued but not yet picked up by the Yahoo Finance RSS feed, or (3) speculation or chat-room activity driving retail trading. For biotech stocks of this size, clinical development milestones, regulatory decisions, or financing announcements are the most common fundamental catalysts, but none are evident here.

NMPAR

NMP Acquisition Corp. Right

$0.23+$0.09

+56.1%

NASDAQ

NMP Acquisition Corp announced execution of a definitive business combination agreement with Gibson Technical Services, a telecom infrastructure company with $140 million 2025 revenue and 12.5% EBITDA margin growing 36% year-over-year, likely driving the 56% jump in the rights offering.

The headline establishes that NMP Acquisition Corp completed a definitive merger agreement with Gibson Technical Services, a profitable telecom infrastructure platform showing strong growth metrics ($140M revenue, 36% YoY growth, 12.5% EBITDA margin). SPAC rights typically rally sharply on announcement of a merger with an established, revenue-generating target rather than a speculative startup. The market is pricing in value from GTS's demonstrated profitability and growth trajectory. However, the headline does not specify valuation terms, deal timing, or other structural details that could affect post-merger returns, so the price action reflects initial enthusiasm for the merger concept rather than a fully informed assessment of deal quality.

OLB

The OLB Group, Inc.

$0.27+$0.13

+48.7%

BNC

CEA Industries Inc.Industrials

$5.24+$1.68

+48.4%

NASDAQ · Mkt cap $108 M

No news headlines were found in the last 48 hours for BNC, so the cause of the 48.42% jump cannot be directly established. This magnitude of move typically reflects either a significant corporate announcement, earnings catalyst, or other material event not yet captured in the sources checked.

The absence of recent news headlines makes it impossible to pinpoint the driver of BNC's strong gain. A move of nearly 50% in a single day on a stock trading under $6 could stem from several sources: a delayed earnings release or earnings beat that has not yet propagated to Yahoo Finance RSS, a merger or acquisition announcement, regulatory approval for a key product or contract, analyst upgrades, short covering, or retail momentum following social media attention. Without access to company filings, press releases, or broader news wires beyond the 48-hour Yahoo window, we cannot confidently attribute the move to any specific catalyst. The rank as the 7th biggest gainer suggests this was a broad market observation, not an isolated event.

CUEN

Cuentas Inc.Technology

$0.48+$0.14

+42.4%

NASDAQ · Mkt cap $5.4 M

No headlines were published about Cuentas Inc. in the last 48 hours, so the 42% gain on September 8 cannot be attributed to disclosed news. The move likely reflects technical trading, short covering, or undisclosed developments.

Yahoo Finance returned zero headlines for Cuentas Inc. in the 48-hour window preceding this 42% jump, which is significant because a stock ranking among the top 8 daily gainers typically warrants news coverage if a major announcement occurred. The absence of news could mean the catalyst was released through alternative channels, priced in before the snapshot date, or entirely non-fundamental in nature. For a micro-cap trading at $0.48, the most common drivers of such moves are short squeezes or covering rallies, technical breakouts above resistance levels, or undisclosed developments not yet picked up by major financial news aggregators. Without verifiable headline evidence or details about the stock's structure, sector, or prior volatility pattern, pinpointing the specific cause is not possible from the data provided.

PDSB

PDS Biotechnology CorpHealthcare

$0.31+$0.09

+39.9%

NASDAQ · Mkt cap $11 M

PDS Biotech announced a $22.55 million financing led by prominent investor Dr. Patrick Soon-Shiong, who will join the board, coupled with progress on the PDS0301 immunocytokine program, driving the 39.89% gain.

The headline establishes a concrete positive catalyst: a named funding round of $22.55 million from a well-known biotech investor and entrepreneur, combined with board involvement and a clinical development milestone. For early-stage biotech stocks trading at depressed prices, institutional backing from a credible, high-profile investor typically signals confidence in the science and reduces perceived dilution risk. The announcement also confirms active progress on PDS0301 in solid tumors, which addresses a material uncertainty for investors. This combination of fresh capital, strategic validation, and program momentum is a textbook catalyst for a single-day 40% move in a micro-cap biotech stock with low trading volume. The timing of the announcement at 12:30 UTC on the snapshot date aligns directly with the price jump.

ETS

ELITE EXPRESS HOLDING INCIndustrials

$1.10+$0.31

+37.3%

NASDAQ · Mkt cap $54 M

No news headlines were published in the last 48 hours, so the 37.35% gain cannot be attributed to a confirmed announcement or earnings beat; the move likely reflects technical trading, a delayed press release, or market rumors.

Elite Express Holding Inc experienced a substantial single-day rally of 37.35% while ranked among the top ten gainers, yet no news headlines appear in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect between price action and available public information is notable. For a micro-cap or low-priced stock like ETS at $1.10, such moves can be triggered by several categories of events: a press release issued but not yet widely indexed by news aggregators, short covering or technical bounce from oversold conditions, unconfirmed rumors circulating on retail trading forums, or a delayed earnings result or corporate announcement that has not yet surfaced in mainstream financial feeds. Without confirmed headlines, the specific catalyst remains unidentified.

SST

SPDR Blmbg Barclays ST Treasury ETFIndustrials

$5.03+$1.39

+36.4%

NYSE · Mkt cap $22 M

A major discrepancy exists: the ticker SST is a short-duration Treasury ETF, but the only news provided is about System1 Inc.'s MapQuest user growth. The 36% jump cannot be explained by the MapQuest announcement alone, and a ticker/company mismatch may have occurred.

The news headline describes System1 Inc. announcing 2 million new MapQuest users over one week, which is a user acquisition metric but not typically a catalyst for a 36% single-day move in an established tech company. However, there is a critical structural issue: SST as listed on NYSE should refer to the SPDR Bloomberg Barclays Short Treasury ETF, a bond fund tracking short-duration U.S. Treasuries. System1 Inc. trades under ticker SST on NYSE, creating ambiguity. If this is truly System1 Inc., the MapQuest news alone is unlikely to drive such volatility without additional context about earnings, guidance, or market sentiment shifts. If this is the Treasury ETF, the move would reflect a sharp repricing of short-term Treasury yields, which the news snippet does not address. Without clarity on which security is moving, causality cannot be firmly established.

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.02+$0.00

+34.2%

NASDAQ · Mkt cap $1.1 M

No news headlines were reported in the last 48 hours for WTER, so the 34% gain on a penny stock is likely driven by technical factors, retail interest, or unreported catalysts rather than a specific corporate announcement.

The absence of any Yahoo Finance headlines in the preceding 48 hours means we cannot point to an earnings release, partnership, product approval, or guidance change as the cause. WTER trades at $0.02, placing it in the micro-cap penny stock category where price moves are often driven by low volume, retail sentiment shifts, technical bounces off support levels, short covering, or social media momentum rather than fundamental news events. The stock may have rebounded from a recent low or benefited from broader sector interest in beverage or alternative water companies, but without accompanying news or volume data we cannot confirm the specific trigger. The 34% single-day jump is material in absolute terms but typical volatility for illiquid securities at this price level.

MOBX

Mobix Labs, Inc.Technology

$1.27+$0.33

+34.0%

NASDAQ · Mkt cap $18 M

Mobix Labs announced it secured its initial F-16 component production order with EMI-filtered connectors already shipping, expanding its defense aircraft footprint and driving a 34% gain on the news.

The headline cluster from September 8 establishes a concrete catalyst: Mobix Labs won its first production order for F-16 fighter jet components, specifically EMI-filtered connectors, with deliveries already underway. CEO Phil Sansone characterized this as another expansion of the company's presence across major U.S. military aircraft programs, signaling both the strategic importance of the win and an existing track record in defense aerospace. For a small-cap company trading at $1.27, a first major production order from a legacy U.S. fighter platform represents material revenue visibility and validation of its technology in high-reliability defense applications. The multiple press releases within hours suggest the company prioritized rapid dissemination, which typically indicates confidence in the announcement's significance.

SWVL

Swvl Holdings Corp.

$6.43+$1.54

+31.5%

TTRX

Turn Therapeutics Inc.Healthcare

$12.67+$2.71

+27.7%

NASDAQ · Mkt cap $295 M

The provided news concerns NovaBridge's board appointment, not TTRX, creating a mismatch between the headline and the stock ticker. The 27.65% gain likely stems from an undisclosed catalyst unrelated to the news snippet shown.

The headline references NovaBridge appointing Martin Dewhurst as an independent director, not Turn Therapeutics (TTRX). This appears to be a data error or mismatched news feed. Without verified news directly tied to TTRX, the true driver of the 27.65% single-day jump remains unknown. For a clinical-stage or small-cap biotech like TTRX, such large moves typically correlate with clinical trial results, FDA decisions, capital raises, partnership announcements, or major insider transactions. The board appointment news provided does not explain TTRX's move and should not be attributed to it.

BCSS.WT

Bain Capital GSS Investment Corp. WT

$0.79+$0.17

+27.4%

ORBS

Eightco Holdings Inc.Consumer Cyclical

$1.14+$0.24

+26.8%

NASDAQ · Mkt cap $257 M

The provided news headline is about Bitmine (NYSE: BMNR), a different company, not Eightco Holdings (ORBS). No direct news explanation for the 26.79% gain is available in the source material.

The headline discusses Bitmine's Ethereum purchase and is unrelated to Orbs. Without news directly tied to ORBS, the jump could reflect several typical catalysts for small-cap NASDAQ stocks: technical bounce from oversold levels, short covering, broader sector rotation into cryptocurrency or blockchain-adjacent plays, or unannounced company developments that have not yet reached public financial news feeds. Eightco Holdings is a relatively illiquid name, so even modest buying pressure or algorithmic reversals can produce outsized percentage moves. The fact that it ranks 17 in daily gainers despite no identified news suggests either institutional reallocation, retail momentum, or a catalyst not captured in the Yahoo Finance RSS snapshot provided.

TWLVR

Twelve Seas Investment Company III Rights

$0.11+$0.02

+26.0%

NASDAQ

No news headlines were found in the last 48 hours, but TWLVR is a SPAC rights offering which can exhibit sharp price moves on redemption activity, warrant exercise patterns, or shifts in the underlying company's valuation or timeline.

The absence of news in the Yahoo Finance RSS feed over the last 48 hours means we cannot point to a specific catalyst such as earnings, guidance, M&A, or regulatory action. TWLVR is a rights offering tied to Twelve Seas Investment Company III, a special purpose acquisition vehicle structure. These instruments are sensitive to redemption windows, sponsor actions, shareholder votes on business combinations, changes in the trust account, and perceived shifts in deal probability or timing. A 26% single-day gain on a security trading at $0.11 could reflect technical factors like low liquidity, closing of a redemption window, updated proxy filings, or accumulated market expectations ahead of an announced milestone. Without access to the full news ecosystem or company filings from the exact snapshot date, the specific trigger remains unclear, though SPAC-related structural events are the most plausible category.

OCTO

Eightco Holdings Inc

$1.14+$0.23

+25.6%

BJDX

Bluejay Diagnostics, Inc.Healthcare

$1.03+$0.21

+25.3%

NASDAQ · Mkt cap $1.0 M

Bluejay Diagnostics announced a federal healthcare partnership with Lovell Government Services on 2026-09-08 establishing procurement infrastructure and distribution across VA, DoD, and military health systems, driving the 25.32% gain as a major commercial milestone ahead of FDA clearance.

The company issued two press releases on the same date announcing a partnership that builds what executives describe as a "commercial pathway" and "federal procurement infrastructure" for its Symphony platform across multiple government healthcare channels. This represents a concrete step toward revenue generation, though the releases carefully note that full commercialization remains dependent on FDA regulatory authorization. For a micro-cap diagnostic company trading near $1.03, securing federal distribution agreements before product clearance is typically viewed as a de-risking event and proof of market demand. The timing of two separate headlines emphasizing the same deal and its significance to federal markets suggests the company intended to maximize visibility. The 25.32% single-day jump is consistent with investor enthusiasm for a pre-revenue or early-revenue company validating its go-to-market strategy with a named, credible partner.

GSRFR

GSR IV Acquisition Corp. Rights

$1.74+$0.35

+25.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 25% jump in GSRFR rights shares likely reflects either a SPAC-related corporate action, delayed news picking up traction, or technical movement in a thinly-traded security.

The absence of recent news headlines is notable given the substantial 25% one-day gain. GSRFR is a rights offering associated with GSR IV Acquisition Corp., a SPAC vehicle. Rights typically experience sharp moves tied to warrant exercises, merger announcement timelines, redemption deadlines, or shifts in the underlying SPAC's deal status or valuation. Without current headlines available, the catalyst could be a previously announced event coming into effect, a delayed market reaction to older news, or exogenous technical factors common in illiquid warrant and rights markets. Thinly-traded securities in the sub-$2 range can also exhibit outsized percentage swings on modest absolute volume shifts. The ranking as the 21st biggest gainer suggests this was a notable market-wide mover today, which might indicate broader chatter or an event not yet captured in major RSS feeds.

TRUG

TruGolf, Inc.Consumer Cyclical

$0.44+$0.09

+24.9%

NASDAQ · Mkt cap $1.2 M

TruGolf announced a binding distribution agreement with TruGolf Canada Inc. granting exclusive master distribution rights in defined Canadian and Indigenous markets, likely driving the 24.92% intraday gain as investors view this as significant geographic expansion.

The company released two related announcements on the same day regarding a legally binding Memorandum of Understanding with TruGolf Canada Inc. that provides exclusive master distribution rights across defined Canadian and Indigenous market opportunities. The headlines characterize this as market expansion and indicate the parties are working toward a longer-term agreement. For a micro-cap stock trading at $0.44, a concrete distribution deal with geographic exclusivity in a new market represents meaningful business development. The timing of both announcements on the same trading day and their prominence in the news feed suggest this was the primary catalyst. The gain ranks 22 among daily movers, which is consistent with material news for a company of this size. No earnings misses, regulatory setbacks, or other negative developments are mentioned, making the distribution agreement the most logical explanation for the positive price action.

SUNE

Pineapple Energy Inc.Technology

$2.36+$0.58

+24.6%

NASDAQ · Mkt cap $9.2 M

Suniva (SUNE's parent/related entity) announced completion of an $835 million capital raise to build a second solar cell manufacturing facility and quadruple capacity to 5.5 GW, driving a 24.6% rally in the stock.

The headline directly references a major capital raise and capacity expansion announcement from Suniva, the U.S. solar cell manufacturer. Completion of $835 million in funding to construct a second major manufacturing facility and quadruple production capacity to 5.5 GW represents significant growth infrastructure. This type of announcement typically catalyzes bullish investor sentiment in solar manufacturing stocks because it signals increased revenue potential, market share gains, and operational scale. The announcement came on the day of the move, making timing alignment clear. Without additional context on financing terms, debt ratios, or near-term profitability, it is reasonable to infer the market interpreted this as a positive development for growth and competitive positioning in U.S. solar manufacturing.

HCWC

Healthy Choice Wellness Corp.Consumer Defensive

$8.68+$1.69

+24.2%

NYSE · Mkt cap $7.4 M

The provided headline about data center market projections appears unrelated to Healthy Choice Wellness Corp., a wellness-focused company; the 24% gain likely stems from an undisclosed catalyst not captured in the news feed provided.

The single headline provided discusses the global data center market reaching $517 billion by 2030, which has no obvious connection to Healthy Choice Wellness Corp.'s core business in wellness products or services. This suggests either the news aggregator captured an irrelevant story or the actual catalyst driving today's gain was not included in the 48-hour window shown. For a wellness stock of this size experiencing a 24% single-day jump, typical catalysts would include positive clinical trial results, a major partnership or distribution agreement, upgraded analyst guidance, institutional buying interest, or short-squeeze dynamics. Without access to company-specific announcements, insider trades, or short interest data, we cannot determine which mechanism is at play here.

SVRN

OceanPal Inc.Industrials

$11.17+$2.17

+24.1%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 24% gain cannot be attributed to a specific disclosed catalyst. The move likely reflects either delayed market reaction to earlier news, technical trading, or undisclosed company developments.

OceanPal Inc. is a shipping company, and the stock jumped 24% on September 8, 2026 with no news reported in the most recent 48-hour window. This gap between price action and available headlines suggests either that relevant news was published more than 48 hours prior and is now being priced in, or that the move is driven by factors other than public announcements. Shipping stocks are sensitive to commodity prices, freight rates, vessel valuations, and fleet utilization. Positive developments in those areas, or short covering in a thinly traded stock, could explain such a move. Without access to earlier news or real-time data, we cannot pinpoint the specific trigger with confidence.

FLZH

Flash Sports & Media Holdings, Inc.Communication Services

$0.10+$0.02

+22.5%

NASDAQ · Mkt cap $60 M

No news headlines were found in the last 48 hours to explain the 22.5% gain in FLZH. The move likely reflects technical trading, short-covering, or undisclosed corporate activity in this penny stock.

Flash Sports & Media Holdings is a micro-cap stock trading at $0.10, and no recent news was available via Yahoo Finance to account for the substantial one-day gain. Penny stocks and very low-priced equities are prone to outsized moves driven by factors other than fundamental news, including short squeezes, algorithmic or retail trading volume spikes, or delayed press releases not yet picked up by major financial feeds. It is also possible that a material announcement was made through the company's own channels but has not yet propagated through mainstream news aggregators. Without headlines or clear corporate action identified, the most likely categories of cause are technical momentum, liquidity events, or information asymmetry between insiders and public markets.

APMCR

AmperCap Acquisition Company Right

$0.11+$0.02

+22.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 22.20% gain in APMCR likely reflects either technical trading activity, delayed market reaction to an announcement not yet indexed, or speculative positioning in a low-priced security.

APMCR is a SPAC rights offering trading at $0.11, a microstructure that makes it sensitive to both fundamental developments in its underlying merger target and technical factors like short covering or retail trading momentum. Without recent news from Yahoo Finance, the sharp single-day gain could stem from several sources common to this security type: announcement of a merger agreement or target selection that has not yet propagated to major news feeds, options-related hedging or gamma effects on a thin order book, accumulation by retail traders attracted to low absolute prices, or reversal of prior selling pressure. SPAC rights tend to trade on momentum and liquidity conditions as much as news. The rank as a top twenty-seven gainer suggests this move was broad enough to register on scanner lists, which typically indicates either coordinated retail interest or a material catalyst that Yahoo Finance has not yet indexed.

NUAI

New Era Energy & Digital, Inc.Technology

$6.60+$1.19

+22.0%

NASDAQ · Mkt cap $562 M

No news headlines were found in the last 48 hours for NUAI, so the 22% gain on September 8, 2026 cannot be tied to a specific announced catalyst and likely reflects technical momentum, delayed information, or market speculation in a smaller-cap name.

The absence of news in the Yahoo Finance RSS feed over the past two days makes it impossible to identify a concrete event driving this substantial gain. NUAI appears to be a small-cap or micro-cap stock based on its price point and ranking as the 28th biggest gainer. Possible explanations for a 22% jump without recent headlines include delayed reaction to older news that may not yet be fully indexed, technical factors such as short covering or algorithmic buying triggered by price levels or volume thresholds, market rumors or social media activity not yet reflected in major news outlets, insider activity ahead of an unannounced event, or simply thin-stock momentum amplification. Without access to the company's investor relations announcements, SEC filings, or real-time market commentary, attributing this move to any specific cause would be speculative.

OESX

Orion Energy Systems IncIndustrials

$30.50+$5.43

+21.7%

NASDAQ · Mkt cap $76 M

Orion Energy Systems announced a second major multimillion-dollar data center lighting engagement with a global hyperscaler, following its inaugural deal, driving a 21.66% gain as the company demonstrates traction in the high-margin data center segment.

The headline establishes that Orion announced an additional multimillion-dollar data center contract with a major hyperscaler, explicitly noting this follows an inaugural multimillion-dollar initiative with the same or similar customer. This signals that Orion has moved beyond a one-time deal to establishing a repeatable business relationship in the data center lighting space, a sector experiencing explosive demand as hyperscalers expand AI and cloud infrastructure. The timing of the announcement on the same day as the price move suggests investors responded positively to evidence of business momentum and revenue visibility in a high-growth customer segment. The rank as the 29th biggest gainer indicates broad market recognition of the news. No earnings report, guidance change, or other catalyst is mentioned in the provided headlines, so the move appears driven directly by this contract announcement.

YDES

YD BIO LIMITEDHealthcare

$4.28+$0.76

+21.5%

NASDAQ · Mkt cap $317 M

No news headlines were found in the last 48 hours to explain YDES's 21.47% gain, so the driver remains unknown; biotech stocks often move on clinical trials, regulatory decisions, or market sentiment shifts that may not immediately appear in headlines.

YDES jumped more than 21% on September 8, 2026, but no financial news, regulatory announcements, earnings reports, or corporate developments appear in the Yahoo Finance RSS feed for the preceding 48 hours. This disconnect suggests the catalyst either occurred earlier than the headline search window, emerged from a non-mainstream source, or reflects intraday trading dynamics such as short covering, options activity, or broader sector momentum. For a small-cap biotech stock, typical catalysts include phase trial results, FDA actions, clinical milestone announcements, or changes in analyst coverage. Without headlines, it is impossible to pinpoint which, if any, of these occurred. The absence of news does not rule out an announcement made directly by the company or covered by specialized biotech news outlets outside the general RSS feed captured here.

KPLT

Katapult Holdings, Inc.Technology

$9.52+$1.63

+20.6%

NASDAQ · Mkt cap $29 M

No news headlines were found in the last 48 hours, so the 20.6% gain on KPLT likely reflects technical trading, options activity, short covering, or a delayed market reaction to an earlier event not captured in the news feed.

Katapult Holdings experienced a significant jump to rank 31st among daily gainers without any identifiable news catalyst in the most recent 48-hour window. This disconnect between price action and reported headlines suggests several possible explanations. First, the move could reflect technical or algorithmic trading triggered by price levels or volume thresholds. Second, options-related activity such as gamma squeezes or short covering could have driven the rally, particularly if KPLT has a volatile or heavily shorted profile. Third, the catalyst may have been announced or discussed prior to the 48-hour window but is only now driving broader buying interest. Fourth, an unconfirmed rumor, social media activity, or analyst commentary not yet reflected in headline aggregators could be propelling the move. Without corresponding news, the exact driver remains speculative.

NUR

Nuran Wireless Inc.

$2.42+$0.37

+20.3%

LABT

Lakewood-Amedex Biotherapeutics Inc.Healthcare

$2.13+$0.38

+20.3%

NASDAQ · Mkt cap $3.8 M

Lakewood-Amedex Biotherapeutics announced it will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 8, 2026, likely driving investor interest and a 20.26% single-day gain in this clinical-stage biotech stock.

The only headline provided is the company's announcement of a presentation slot at a major investment conference. While conference presentations alone are typically routine events, for clinical-stage biotechnology companies they often serve as platforms to discuss pipeline progress, clinical trial data, or partnership developments that may not have been previously disclosed. The timing of the announcement coinciding exactly with the trading date and the stock's inclusion in the top 33 gainers suggests investors reacted positively, possibly anticipating material updates at the conference or viewing the presentation as validation of the company's advancement. However, the headline does not specify what LABT will present or announce, so the move could also reflect broader market sentiment toward antimicrobial biotech or accumulated buying pressure ahead of the event rather than a specific disclosed catalyst.

JDZG

JIADE LimitedConsumer Defensive

$3.64+$0.60

+19.7%

NASDAQ · Mkt cap $23 M

No news headlines were found in the last 48 hours for JDZG, so the 19.74% gain lacks an identified news catalyst. The jump may reflect technical trading, a delayed announcement, or market speculation in a low-liquidity stock.

Yahoo Finance returned no headlines for JDZG in the past 48 hours, which means we cannot point to a specific corporate event—earnings, guidance, partnerships, regulatory approval, or management changes—that would explain the nearly 20% single-day rally. JDZG is a micro-cap stock trading on NASDAQ, and such stocks are prone to intraday volatility driven by factors other than fundamental news: short covering, algorithmic rebalancing, social media attention, or delayed press releases not yet indexed by the RSS feed. It is also possible that news was released but has not propagated to this data feed yet. Without additional context on the company's sector, short interest, or trading volume patterns, attributing the move to a specific cause would be speculation.

ASPCR

A SPAC III Acquisition Corp.

$0.11+$0.02

+19.4%

NASDAQ

No news headlines were found in the last 48 hours, so the 19.44% gain in this SPAC stock likely reflects either a technical bounce, reduced selling pressure, or an untracked rumor or announcement not yet indexed by Yahoo Finance.

ASPCR is a blank-check acquisition vehicle trading at $0.11, well below typical SPAC par value, which suggests it may be in liquidation, dissolution, or post-deal wind-down. The absence of any news in the last 48 hours makes it difficult to attribute the move to a specific catalyst. SPAC securities at these price levels often see volatile swings driven by low liquidity, algorithmic or retail technical trading, short covering, or rumors not yet surfaced in major media. Without corroborating news, the jump appears to be driven by either technical factors (oversold bounce, relative value hunting among penny stocks), reduced short positions, or word-of-mouth catalysts that have not yet reached financial news feeds. Typically, blank-check vehicles near liquidation can see sudden moves on dissolution schedule changes, creditor actions, or charter extension votes.

LTCH

Latch, Inc.Technology

$0.18+$0.03

+19.4%

NASDAQ · Mkt cap $31 M

No headlines were found in the last 48 hours, so the 19.44% jump in Latch stock cannot be attributed to a disclosed news catalyst. The move is likely driven by technical factors, short covering, or undisclosed market developments.

Latch is a microcap building technology company that has historically experienced volatile trading with minimal liquidity. When no news is available to explain a single-day gain of this magnitude, the most probable causes include short-squeeze dynamics (given the stock's micro-cap status and typical short interest), technical bounce from oversold conditions, or retail trading momentum. Latch's share price has traded well below a dollar, making it susceptible to outsized percentage moves on relatively modest absolute dollar volume. Without a confirmed catalyst in the headlines, this appears to be a liquidity and technicals-driven event rather than a fundamental development. Sector tailwinds, delayed press releases not yet indexed, or insider activity are secondary possibilities that cannot be verified from the data provided.

ATNM

Actinium Pharmaceuticals Inc

$1.23+$0.20

+18.9%

FCEL

FuelCell Energy IncIndustrials

$17.77+$2.82

+18.9%

NASDAQ · Mkt cap $1.2 B

FCEL rose 18.87% likely driven by positive sentiment in the fuel cell sector following Bloom Energy's S&P 500 inclusion and Plug Power's strong performance, both announced in the past 48 hours, signaling broader tailwinds for hydrogen and fuel cell equities.

The provided headlines do not directly mention FCEL or any company-specific catalyst for this stock. However, two fuel cell sector peers received significant positive attention: Bloom Energy surged on S&P 500 inclusion (forced institutional buying), and Plug Power rallied 10.1% YTD on revenue recovery and rising electrolyzer demand. In capital markets, positive momentum in peer companies within a niche sector often creates a halo effect, driving retail and algorithmic buying across thematically related names. FCEL, as a fuel cell manufacturer competing in the same hydrogen economy space, likely benefited from improved sector sentiment and potential investor rotation into hydrogen-related equities. Without a direct FCEL announcement, this move appears to be sympathy buying and index-driven flows in the fuel cell space rather than company-specific news.

ZJYL

JIN MEDICAL INTERNATIONAL LTD. - Ordinary SharesHealthcare

$2.02+$0.39

+18.8%

NASDAQ · Mkt cap $24 M

No news headlines were available in the last 48 hours, so the cause of ZJYL's 18.75% jump cannot be determined from public reporting. The move likely reflects a small-cap biomedical stock responding to technical factors, rumors, or delayed announcements not yet captured in financial news feeds.

The absence of recent news headlines makes it impossible to identify a specific catalyst for this substantial single-day gain. Jin Medical International is a small-cap medical device or biotech company trading on NASDAQ, and stocks in this category are sensitive to several factors that may not immediately appear in mainstream news aggregators. Possible explanations include a positive clinical trial result or regulatory decision announced through company channels before wire service pickup, a technical or short-covering rebound, analyst commentary, insider activity, or sector momentum. Without corroborating headlines or company disclosures, any specific cause remains speculative. The 18.75% move suggests genuine event-driven activity rather than pure noise, but the nature of that event is not documented in the sources provided.

ROIV

Roivant Sciences Ltd.

$41.48+$6.54

+18.7%

TWG

Top Wealth Group Holding Limited Ordinary SharesConsumer Defensive

$0.52+$0.08

+17.8%

NASDAQ · Mkt cap $22 M

No headlines were found in the last 48 hours to explain the 17.83% gain in TWG stock on September 8, 2026. The move likely reflects a technical catalyst, delayed news disclosure, or market-driven repricing of a low-priced security.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for this nearly 18% single-day gain. TWG is a low-priced stock trading at $0.52, which typically exhibits higher volatility and can be more susceptible to retail interest, short covering, or liquidity-driven moves. Possible categories of catalyst include a delayed earnings announcement or regulatory filing that may not yet have been picked up by news aggregators, accumulation by institutional investors or activist interest, short squeeze activity common in penny stocks, or a sector rotation favoring wealth management or financial services. Without access to company filings, insider activity, or real-time order flow data, it is not possible to distinguish between these scenarios. The lack of headline coverage suggests this move may be technically or sentiment-driven rather than event-driven.

ARBE

Arbe Robotics Ltd.Technology

$0.74+$0.11

+17.7%

SLE

Super League Gaming IncCommunication Services

$4.64+$0.69

+17.5%

NASDAQ · Mkt cap $6.6 M

No news headlines were found in the last 48 hours explaining Super League Gaming's 17.47% gain today, so the catalyst remains unclear and could stem from technical trading, delayed announcements, or sector-wide movements.

Super League Gaming experienced a significant single-day rally of over 17 percent with no corresponding news coverage visible in the Yahoo Finance RSS feed during the preceding 48 hours. This disconnect between price action and public headlines is common in smaller-cap stocks where catalysts may include retail trading activity, short covering, sector rotation into gaming or esports-related names, or previously announced developments finally gaining traction. Without access to earnings results, partnership announcements, or other corporate events released outside the major news feeds, it is not possible to identify a specific fundamental driver. The stock's rank as the 43rd biggest gainer suggests broad market interest today, but the cause cannot be determined from the available information.

PAAI

Arena Group Holdings Inc

$1.03+$0.15

+16.6%

SEI

Solaris Energy Infrastructure, Inc.

$63.99+$8.95

+16.3%

AVAT

Avalanche Treasury CorporationFinancial Services

$0.85+$0.12

+15.7%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 15.65% gain cannot be attributed to a specific announced catalyst. The move likely reflects technical trading, delayed reporting of prior events, or market speculation in this micro-cap security.

The absence of recent headlines is significant because a 15.65% single-day move in a NASDAQ-listed stock would typically be accompanied by news if driven by fundamentals. Avalanche Treasury Corporation appears to be a micro-cap security, and such stocks are particularly susceptible to technical momentum, short covering, or thin-volume rallies that can swing sharply without corresponding news flow. It is also possible that a material announcement was made but has not yet surfaced in the Yahoo Finance RSS feed, or that the move reflects a delayed market reaction to older news not visible in the 48-hour window. Without access to company filings, insider activity, or social media catalysts, we cannot identify a specific driver.

SATL

Satellogic Inc.Industrials

$5.35+$0.70

+15.1%

NASDAQ · Mkt cap $713 M

Satellogic announced the appointment of Vice Admiral Frank "Trey" Whitworth, former NGA director, as President on 2026-09-08, a high-profile leadership move likely signaling strengthened defense and intelligence sector credibility that drove the 15% intraday gain.

The headline establishes a clear leadership appointment with explicit relevance to the company's stated strategy. Vice Admiral Whitworth's background as director of the National Geospatial-Intelligence Agency (NGA) and his transition from strategic advisor to President carries material weight for a satellite intelligence company positioning itself around government and defense contracts. The news release emphasizes his role in leading "Global Operations and Defense and Intelligence Strategy," which directly addresses the market's historical valuation concerns around Satellogic's ability to win and execute sovereign-trusted contracts. This is a common positive catalyst for space/defense contractors: credentialed leadership appointments that reduce execution risk or signal insider confidence in the business model. The timing of the announcement at market open and the stock's rank as 47 biggest gainer suggest the market interpreted this as moderately significant validation.

GWH

ESS Tech, Inc.Industrials

$0.39+$0.05

+14.9%

NYSE · Mkt cap $23 M

No news headlines were found in the last 48 hours, so the +14.86% gain likely reflects technical trading, short covering, or delayed market reaction to an older catalyst not captured in the provided headlines.

ESS Tech is a long-duration energy storage company, and shares of such firms can be volatile on modest trading volume. With no recent news available to explain the move, the jump may reflect several common drivers for small-cap stocks: short covering or squeeze dynamics, technical chart momentum, accumulation by larger holders, or delayed market digestion of older announcements not visible in the most recent headlines. Energy storage stocks have also been subject to broader sector rotation and regulatory sentiment around battery technologies and grid modernization. Without a specific catalyst visible in the last 48 hours, it is difficult to isolate a single cause, though the gain is material enough to warrant checking for after-hours news, insider activity, or analyst notes that may not have propagated to the RSS feed yet.

SMR

NuScale Power Corporation

$11.18+$1.42

+14.7%

LIQT

LiqTech International IncIndustrials

$0.65+$0.08

+14.4%

NASDAQ · Mkt cap $18 M

No news headlines were found in the last 48 hours, so the 14.4% gain on LIQT is unexplained by publicly available recent announcements; the move may reflect technical trading, delayed news dissemination, or market rumors.

LiqTech International is a small-cap water treatment and air purification technology company traded on NASDAQ, and a 14.4% single-day move in this price range is not uncommon for thinly traded micro-cap stocks. Without any news headlines in the past 48 hours to anchor the move, several categories of catalyst are possible. First, there could be a delay in news dissemination to Yahoo Finance's RSS feed, meaning a material announcement was made but has not yet appeared in this snapshot. Second, the move could be driven by technical factors such as short covering, options expiration effects, or momentum trading in a stock with low daily volume. Third, it could reflect market rumors or social media discussion not yet formalized into press releases. LiqTech's small market cap and limited trading liquidity make it susceptible to outsized moves on modest trading interest.

Biggest Losers

Tue, Sep 8, 2026 50

ARCI

Appliance Recycling Centers of America IncFinancial Services

$10.10−$9.58

-94.8%

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$1.32−$3.17

-70.3%

NASDAQ · Mkt cap $9.6 M

No news headlines were found in the last 48 hours to explain the 70% drop, suggesting the catalyst may be a delayed announcement, technical event, or rumor not yet captured in the provided sources.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours is notable given the severity of the decline. LHSW is a micro-cap international stock trading on NASDAQ, and such securities are susceptible to sharp moves driven by factors including delayed regulatory filings, insider trading announcements, reverse splits, delisting notices, or unverified rumors circulating on message boards or social media before formal news dissemination. The stock's low price and apparent illiquidity typical of smaller-cap international plays could amplify volatility. Without headline confirmation, the move could also reflect a technical breakdown following failed support or margin-driven selling, though the magnitude suggests a material event rather than pure technicals.

FCUV

Focus Universal, Inc.Technology

$5.84−$12.44

-68.1%

NASDAQ · Mkt cap $5.7 M

Focus Universal announced exercise of warrants for $3.7 million in gross proceeds on September 8, a dilutive capital raise that likely triggered the 68% single-day collapse alongside possible broader market concern about the company's financial position.

The warrant exercise announcement itself is a factual event, but the magnitude of the stock's decline (68% in one day, ranking 3 biggest loser) suggests either severe negative sentiment beyond the warrant news alone or a confluence of factors. Warrant exercises are dilutive and can signal financial distress, but a $3.7 million raise on a stock that lost roughly $13 per share in market value indicates the market may be pricing in deeper concerns about the company's viability, competitive position, or previously unrevealed financial results. The headline provided is incomplete (ends mid-sentence), so critical details about warrant terms, conversion prices, or accompanying commentary are missing. Without earnings results, guidance cuts, or other major announcements in the last 48 hours, the warrant exercise appears to be the only identified catalyst, though the severity of the move suggests investors may have interpreted it as a sign of acute capital strain.

RETO

Reto Eco-solutions IncBasic Materials

$0.50−$0.57

-53.1%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 53% single-day drop in RETO cannot be tied to a specific disclosed event; the move likely reflects either a delayed market reaction to prior news, a technical or liquidity event, or undisclosed corporate news.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours makes it impossible to pinpoint a specific catalyst for this dramatic 53% single-day decline. For a small-cap eco-solutions stock trading at $0.50, several categories of moves are plausible without confirmed headlines: a delayed market reaction to earnings or guidance released earlier in the week, a short squeeze reversal, a sudden loss of investor confidence following unconfirmed rumors, or a technical breakdown in a thinly traded security. It is also possible that material news exists but has not yet been indexed by the RSS feed, or that an insider announcement or regulatory filing triggered the move before broader press coverage. Without access to corporate filings, insider trading databases, or the actual order flow, attributing the cause remains speculative.

CAPNR

Cayson Acquisition Corp Right

$0.09−$0.10

-52.6%

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.01−$0.01

-49.4%

NASDAQ

No news headlines were found in the last 48 hours, so the 49% decline in this warrant cannot be tied to a specific announcement; warrant price collapse is typically driven by underlying stock weakness or time decay as expiration approaches.

The absence of any news in the last 48 hours means the decline cannot be attributed to company-specific events like earnings misses, product approvals, or guidance cuts. BNCWW is a warrant, a derivative security whose value depends on two primary factors: the underlying CEA Industries common stock price and time to expiration. Warrants lose value as they approach expiration, and a 49% single-day collapse at the $0.01 price level suggests either severe deterioration in the underlying stock, rapid time decay as expiration nears, or both. Without access to the current underlying stock price or warrant expiration date, a definitive cause cannot be established, but warrant holders typically face these mechanical pressures independent of news flow.

BIAF

bioAffinity Technologies, Inc. Healthcare

$8.93−$6.44

-41.9%

NASDAQ · Mkt cap $3.3 M

No news headlines were found in the last 48 hours to explain bioAffinity's 41.9% drop on September 8, 2026, so the cause remains unclear without additional information.

The absence of any news in the Yahoo Finance RSS feed over the past two days is notable given the severity of the decline. A 42% single-day loss in a small-cap biotech stock typically reflects a significant negative catalyst, which could include delayed clinical trial results, regulatory rejection, insider selling disclosure, reverse split announcement, dilutive financing, or loss of a key partnership. bioAffinity Technologies operates in the diagnostics and biotech space where binary catalysts around FDA approvals or clinical data are common drivers of large moves. Without headlines, the catalyst could be a press release issued directly by the company, a social media announcement, rumors circulating on retail trading forums, technical breakdown after a resistance break, or material non-public information reverberating through the market ahead of an official announcement. The lack of news coverage does not rule out a genuine corporate event, only that it has not yet been widely reported.

LEXX

Lexaria Bioscience Corp.Healthcare

$9.39−$4.81

-33.9%

NASDAQ · Mkt cap $19 M

Lexaria announced a warrant exercise bringing in $5.9 million in gross proceeds on the same day it released positive DehydraTECH 3.0 absorption data, yet the stock plummeted 33.87%, suggesting the market viewed the warrant dilution or capital raise as significantly negative despite the product news.

The two headlines on September 8 present a mixed picture. Lexaria announced exercise of warrants for approximately $5.9 million in gross proceeds, which typically signals shareholder dilution and often triggers sell-offs in biotech stocks, particularly smaller-cap ones. On the same day, the company released what appears to be positive absorption data from an animal study on amycretin related to its DehydraTECH 3.0 platform. The magnitude of the 33.87% drop suggests the market weighted the dilutive financing announcement far more heavily than the product advancement news. This is not uncommon for early-stage biotech where capital raises can be viewed as a sign of funding desperation or runway concerns, potentially overshadowing incremental technical achievements in drug delivery platforms that remain pre-commercial.

REBN

Reborn Coffee, Inc.Consumer Cyclical

$0.75−$0.36

-32.3%

NASDAQ · Mkt cap $12 M

No news headlines were available in the last 48 hours to explain REBN's 32% drop, so the cause remains unclear; possible drivers include technical selling, sector headwinds, or delayed news not yet surfaced in the RSS feed.

The 32% single-day decline in REBN is substantial, yet Yahoo Finance RSS returned zero headlines in the prior 48 hours. This absence of news does not mean no catalyst occurred—it could indicate that news was released outside the coverage window, came from a source not captured by the feed, or arrived after market close on the prior day. For a micro-cap beverage stock trading at $0.75, typical catalysts include earnings misses, supply chain disruptions, dilutive financing announcements, executive departures, or loss of a major distribution partner. Without substantive information, the move appears to be either a technical correction, sector rotation out of small-cap names, or a delayed market reaction to an event not yet visible in the headline data provided.

LASE

Laser Photonics CorpIndustrials

$0.95−$0.44

-31.6%

NASDAQ · Mkt cap $67 M

No news headlines were found in the last 48 hours, so the 31.58% drop in LASE cannot be attributed to a specific announced event. The decline likely stems from technical selling, market sentiment, or undisclosed company developments.

The absence of recent news headlines makes it difficult to pinpoint a concrete catalyst for the sharp 31.58% decline. However, small-cap stocks like Laser Photonics (trading at $0.95) are typically sensitive to several factors: potential earnings disappointments not yet widely reported, sector headwinds affecting industrial laser or photonics companies, loss of confidence from institutional holders, or technical breakdown through key support levels that can trigger cascade selling in low-liquidity securities. The magnitude of the drop and its ranking as the tenth biggest loser suggests this was not an isolated technical glitch but rather a meaningful repricing. Without access to earnings reports, regulatory filings, insider transactions, or company announcements from the past 48 hours, any specific explanation remains speculative. It's also possible that news existed but was not captured by the Yahoo Finance RSS feed provided.

GRI

Cohen & Steers Global Realty Majors ETFHealthcare

$1.99−$0.88

-30.8%

NASDAQ · Mkt cap $3.1 M

The news headline appears to reference GRI Bio (a biotech company), not GRI the Cohen & Steers Global Realty Majors ETF, making it unrelated to today's 30.76% drop; the actual cause remains unclear from available information.

A critical mismatch exists between the ticker and the headline. GRI trades as a real estate ETF on NASDAQ, but the news discusses GRI Bio's Phase 2a respiratory data presentation, which is an entirely different company. This headline does not explain the ETF's sharp decline. Real estate ETFs typically move on interest rate expectations, property sector earnings, or macroeconomic data. A 30.76% single-day drop is extreme for a diversified real estate fund and suggests either a technical error, a major market shock to the real estate sector, or a reportorial mixup. Without headlines actually tied to the Cohen & Steers fund itself—such as sector rotation, Fed policy shifts, or fund-specific issues—the precise driver cannot be identified from the evidence provided.

JAGX

Jaguar Health IncHealthcare

$0.41−$0.18

-30.7%

NASDAQ · Mkt cap $4.5 M

Jaguar Health announced expansion of its Neonorm product line into the companion-animal market via Amazon launch, but the stock fell 30.67% anyway, suggesting investors may have reacted negatively to execution risks, margin concerns, or unrelated sector headwinds rather than the news itself.

The headlines describe a product-line extension that would ordinarily be viewed as incremental positive news: Jaguar is broadening Neonorm into dogs after establishing it in foals and calves, gaining Amazon distribution. However, the stock dropped sharply on the same day the news was announced, which is counterintuitive. This suggests either the market viewed the expansion as insufficient or underwhelming relative to expectations, investors are concerned about unit economics or gross margins in the companion-animal segment, or the move triggered profit-taking in a stock that may have run up recently. Alternatively, the decline could reflect broader sector weakness in animal health, a short-seller report, or unrelated negative catalysts not captured in the provided headlines. The timing mismatch between positive product news and a large single-day loss indicates market skepticism about the strategic value or near-term impact of the announcement.

FSHPR

Flag Ship Acquisition Corporation

$0.07−$0.03

-29.9%

NASDAQ

No news headlines were reported in the last 48 hours for FSHPR, so the 29.93% drop cannot be directly attributed to a specific company announcement or event based on available evidence.

The absence of any recent news headlines makes it impossible to pinpoint a definitive cause for the sharp decline. However, FSHPR is a blank-check acquisition vehicle, and stocks in this category are sensitive to several structural risks that could trigger sudden drops without accompanying news coverage: deteriorating merger negotiations or the expiration of a deal timeline, insider selling or redemption announcements that occur via SEC filing rather than press release, loss of sponsor confidence, or general liquidity concerns. Additionally, SPAC-related equity may trade on technical factors or shifts in investor sentiment toward the sector. The stock's already low price of $0.07 suggests it may be in or near distress, which can amplify daily percentage moves on modest share volume. Without concrete news or filings reviewed, the specific catalyst remains unclear.

EONR.WT

EON Resources Inc WT

$0.07−$0.03

-28.4%

GELS

Gelteq Limited Ordinary SharesHealthcare

$0.64−$0.25

-28.1%

NASDAQ · Mkt cap $6.0 M

No news headlines were found in the last 48 hours, so the 28% drop on GELS cannot be attributed to a specific announced event; the cause remains unknown without additional context.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours makes it impossible to point to a concrete catalyst for the sharp 28% decline in GELS shares. For a microcap stock trading at $0.64, price moves of this magnitude can result from several sources not captured in major news feeds: a negative filing with the SEC, an announcement made on the company's own channels rather than through newswires, short selling pressure or technical breakdown of support levels, loss of a key contract or partner, or broader sector rotation away from the company's category. Without access to SEC filings, insider trading activity, or direct company announcements made outside traditional news distribution, it is not possible to distinguish between these possibilities. The rank as the 15th biggest loser suggests this was a genuine selloff rather than normal volatility.

TTAN

ServiceTitan, Inc. Class A Common Stock

$81.35−$25.23

-28.1%

YMAT

J-STAR HOLDING CO LTDBasic Materials

$1.35−$0.46

-27.2%

NASDAQ · Mkt cap $7.3 M

No news headlines were found in the last 48 hours to explain the 27.21% drop in YMAT, so the cause remains unclear without additional information.

The absence of any headlines in the Yahoo Finance RSS feed over the past two days means we cannot point to a specific earnings miss, regulatory action, guidance cut, or corporate event as the driver of this sharp decline. YMAT (J-STAR Holding Co Ltd) is a smaller-cap NASDAQ listed company, and stocks of this size can experience volatile single-day moves due to several common mechanisms: thin trading volumes that amplify intraday selling pressure, delayed press release publication not yet reflected in major news feeds, short-squeeze unwinding or forced liquidation of leveraged positions, sector rotation out of the relevant industry, or technical breakdown through a key support level that triggers algorithmic selling. Without access to intraday volume data, insider trading, or confirmation of news timing, it is impossible to distinguish among these possibilities based on the snapshot provided.

EVMN

Evommune, Inc.Healthcare

$13.10−$2.97

-24.2%

NYSE · Mkt cap $436 M

Evommune announced Phase 2b trial results for EVO756 in atopic dermatitis on September 8, likely disappointing investors enough to drive a 24% single-day decline, though the full details of the results are not provided in the headline.

The company released top-line results from a Phase 2b trial for EVO756 in moderate-to-severe atopic dermatitis on the same day as the sharp stock decline. The headline itself does not specify whether results were positive, negative, or mixed, nor does it provide efficacy or safety data. For a clinical-stage biotech company, Phase 2 results are material events that can drive large moves in either direction depending on whether they meet or miss investor expectations. The magnitude of the decline (24% and ranking as the 18th biggest loser) suggests the market interpreted the results unfavorably—either the drug failed to meet primary endpoints, showed concerning safety signals, or fell short of consensus expectations for efficacy or patient benefit. Without access to the detailed results or guidance, the inference that results disappointed is reasonable but not certain.

QUMSR

Quantumsphere Acquisition Corp. Rights

$0.06−$0.02

-23.8%

BENF

BeneficientFinancial Services

$1.80−$0.55

-23.3%

NASDAQ · Mkt cap $33 M

BENF fell 23.3% with no news headlines in the last 48 hours, so the catalyst remains unclear; the drop may reflect broad market weakness, a delayed announcement, or a technical unwind in a thinly traded stock.

No news headlines were found in the last 48 hours to explain BENF's sharp 23.3% decline. Without a specific catalyst such as earnings results, guidance changes, regulatory actions, or material contract announcements, the cause cannot be identified from available public reporting. Beneficient is a financial services company focused on alternative assets, and stocks in this category can be sensitive to credit conditions, wealth management sentiment, and capital markets disruption. The move could reflect sector-wide pressure, a delayed negative announcement not yet picked up by major news feeds, profit-taking in a lower-liquidity name, or technical factors unrelated to fundamental news. Without additional evidence, pinpointing the exact catalyst is speculative.

MODD

Modular Medical, Inc.Healthcare

$2.83−$0.84

-22.8%

NASDAQ · Mkt cap $13 M

MODD fell 22.81% on September 8, 2026, but the two available headlines only announce an upcoming investor conference on September 15-16—no negative news or operational update was disclosed that would explain the sharp drop.

The provided headlines contain no earnings miss, FDA decision, guidance reduction, product failure, management change, or other negative catalyst. Both articles are routine conference participation announcements published on the same day as the stock decline. This disconnect suggests the sell-off was driven by factors not captured in the headlines provided. For a commercial-stage medical device company trading near $2.83, typical catalysts for sharp single-day drops include delayed clinical trial results, loss of a key contract, financing dilution, short-seller reports, or sector-wide weakness in medtech. Without access to news beyond these two conference notices, it is impossible to determine which mechanism caused the decline. The timing of the conference announcement on the same day as the drop is likely coincidental rather than causal.

RTB

RTB Digital, Inc.Technology

$8.92−$2.54

-22.2%

NASDAQ · Mkt cap $181 M

RTB Digital fell 22.16% with no news headlines in the last 48 hours, making the specific cause unclear. The drop likely reflects either a delayed market reaction to an earlier announcement, broad sector weakness, or an untracked catalyst such as an earnings miss, guidance cut, or analyst downgrade.

No headlines were found in the last 48 hours preceding RTB Digital's sharp 22% decline, which means the direct cause is not immediately visible in the provided news feed. This is a significant gap because a move of this magnitude typically has a catalyst. For a digital advertising and programmatic marketing company like RTB Digital, the most common drivers of sharp downside moves include disappointing earnings or revenue guidance, loss of a major customer or advertiser, negative analyst commentary on the sector or the firm's competitive position, margin pressure from rising infrastructure costs, or weakening demand in the digital advertising space. It is also possible the headline was published outside the 48-hour window or was not captured by the RSS feed. Without access to the underlying cause, attribution remains speculative.

SNYR

Synergy CHC Corp.Healthcare

$0.08−$0.02

-20.5%

NASDAQ · Mkt cap $1.6 M

The provided news concerns InnovAge (INNV), not Synergy CHC (SNYR), so no direct headline-driven cause is established for SNYR's 20.51% decline today.

The InnovAge earnings miss headline is unrelated to Synergy CHC and therefore does not explain SNYR's move. Synergy CHC is a small-cap stock trading at $0.08, making it sensitive to sector dynamics, liquidity events, or company-specific developments not captured in the news feed provided. Penny stocks of this nature often experience sharp daily swings due to limited float, technical selling, insider transactions, or delayed disclosure of operational challenges. Without a direct news catalyst tied to SNYR itself, the decline could reflect sector rotation away from healthcare services firms, margin calls in small-cap portfolios, or unannounced company developments that may surface later.

SBXD.WT

SilverBox Corp IV WT

$0.08−$0.02

-20.4%

RNA

Avidity Biosciences Inc

$11.35−$2.83

-20.0%

FTFT

Future FinTech Group IncTechnology

$1.33−$0.32

-19.4%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours to explain FTFT's 19.39% drop, suggesting the move was driven by technical selling, sector weakness, or undisclosed market events.

Yahoo Finance RSS returned zero headlines for Future FinTech Group in the 48 hours preceding this snapshot date. This absence of reported news is notable given the severity of the decline, ranking it 26 among NASDAQ losers. The stock's price of $1.33 indicates a micro-cap or distressed equity, which are often subject to higher volatility and susceptibility to technical breaks, liquidity events, or broad sector rotations without corresponding press coverage. Possible mechanisms include automated stop-loss cascades triggered by a prior breakdown, margin calls in a leveraged portfolio, short-seller activity in a thinly traded name, or delayed disclosure of unfavorable developments. Without headline evidence, the true catalyst remains opaque.

BANL

CBL International Limited - Ordinary SharesEnergy

$6.63−$1.61

-19.4%

NASDAQ · Mkt cap $26 M

No news was reported in the last 48 hours for BANL, so the 19.37% drop likely resulted from a delayed earnings miss, contract loss, or broader market sell-off in its sector—all of which remain unconfirmed without headlines.

The absence of any headlines in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to anchor this sharp 19.37% decline to a specific corporate event. For a stock ranked 27 in daily losers, such a magnitude typically signals either material negative news or a sudden sector rotation. Possible categories include an earnings announcement after hours or pre-market (which might not yet be reflected in news feeds), loss of a major customer or contract, downward guidance revision, or weakness in the broader apparel or retail sector to which CBL International likely belongs. Without access to real-time financial disclosures or earnings calendars, we cannot determine which scenario applies. It is also possible the move reflects delayed market reaction to news released outside the tracked RSS window.

GIPR

Generation Income Properties Inc.Real Estate

$0.43−$0.10

-19.3%

NASDAQ · Mkt cap $253 K

GIPR fell 19.26% with no news reported in the last 48 hours, making the specific catalyst unclear; the move may reflect broader sector weakness, technical selling, or an unannounced development not yet captured in major news feeds.

No headlines are available in the last 48 hours to explain the significant 19.26% decline in GIPR. Generation Income Properties is a mortgage real estate investment trust, a sector sensitive to interest rate expectations, credit spreads, and investor risk appetite. For a REIT trading at $0.43, a single-day drop of this magnitude could plausibly reflect several categories of catalyst: deterioration in an upcoming earnings report before official release, sector rotation out of mortgage REITs due to rising rates or recession fears, technical breakdown below a support level, or an announcement made through channels not yet reflected in Yahoo Finance's headline feed. Without corroborating news, any specific explanation remains inference rather than established fact. The stock's low price point also suggests it may be subject to higher volatility and lower institutional coverage.

TRBG

TURBOGEN LTD

$5.35−$1.28

-19.1%

CYCN

Cyclerion Therapeutics Inc

$3.42−$0.79

-18.8%

NTHI

NEONC TECHNOLOGIES HOLDINGS, INC.Healthcare

$4.06−$0.91

-18.0%

NASDAQ · Mkt cap $120 M

No news headlines were found in the last 48 hours explaining the 18% drop in NTHI stock on September 8, 2026, so the cause cannot be pinned to a specific corporate event.

The absence of recent news is notable for a stock experiencing an 18% single-day loss—typically a move of that magnitude occurs alongside earnings misses, guidance cuts, analyst downgrades, regulatory setbacks, or significant business announcements. Without headlines to reference, the drop could reflect several possibilities: a delayed market reaction to older news not captured in the 48-hour window, a technical or momentum-driven sell-off, rumors or social media catalysts not yet reflected in formal news, sector-wide weakness, or an adverse development that has not yet been publicly disclosed or reported by Yahoo Finance. NEONC Technologies is a micro-cap NASDAQ stock where liquidity is typically thin, making large percentage swings more common from smaller absolute dollar outflows. Without concrete information, determining whether this is value destruction or temporary volatility is impossible.

SGRX

SANGRIX INC. Class A

$1.63−$0.35

-17.8%

BRZE

Braze, Inc. Class A Common StockTechnology

$30.34−$5.73

-17.8%

NASDAQ · Mkt cap $3.7 B

Braze beat Q2 earnings and revenue estimates but issued weak third quarter EPS guidance that fell short of Wall Street expectations, triggering a 17.77% decline as investors repriced growth prospects downward.

On September 8, 2026, Braze reported Q2 results that exceeded analyst estimates on both earnings (beat by 18.75%) and revenue (beat by 3.19%), with sales growing 26.2% year-over-year to $227.2 million. However, the company's forward guidance for Q3 2026 earnings fell short of consensus expectations, which caused the sharp reversal. Multiple sources confirm that the weak EPS guidance drove the after-hours decline, with initial drops reported around 10-12% that accelerated to the final 17.77% loss by market close. This is a classic "beat and miss" pattern where strong historical performance is overshadowed by disappointing forward signals, signaling investor concern about decelerating profitability growth or margin compression ahead despite solid top-line momentum.

ONCO

Onconetix, Inc.Healthcare

$0.84−$0.18

-17.6%

NASDAQ · Mkt cap $2.8 M

No news headlines were found in the last 48 hours, so the 17.65% decline cannot be directly attributed to a specific announced catalyst; the drop likely reflects either technical selling, broader market conditions, or unreported developments.

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours makes it difficult to pinpoint a concrete cause for ONCO's sharp 17.65% drop to $0.84. Biotech and small-cap stocks like Onconetix are sensitive to clinical trial results, regulatory decisions, financing announcements, or shifts in investor sentiment, any of which could occur without immediate headline distribution. The stock trades at a low price point, which can amplify volatility. Possible categories include: delayed reporting of clinical or regulatory news not yet syndicated to major feeds, a private financing event or capital raise at a dilutive valuation, general sector rotation out of small-cap biotech, or technical selling pressure in a low-liquidity name. Without corroborating headlines, however, these remain hypotheses rather than confirmed drivers.

Empire Petroleum Corp

$2.58−$0.54

-17.3%

Scienjoy Holding CorporationCommunication Services

$0.86−$0.18

-17.2%

NASDAQ · Mkt cap $40 M

No news was published in the last 48 hours to explain SJ's 17% drop, so the cause likely stems from technical selling, sector weakness, or delayed market reaction to an earlier event.

Scienjoy Holding Corporation fell 17.16% to $0.86 on September 8, 2026, but no headlines appeared in the prior 48 hours to provide a direct explanation. At this low price point and liquidity tier, micro-cap stocks often experience sharp moves driven by thin trading volumes, automated sell-offs, or spillover from sector rotation rather than company-specific news. Without access to earnings releases, guidance changes, insider transactions, or regulatory filings published in the relevant window, we cannot pinpoint a discrete catalyst. The drop may reflect delayed reaction to an earlier announcement, sentiment shift in a related cohort, or purely technical momentum. Verification of any concurrent news on company websites or SEC filings would be necessary to rule out a material event.

CELG.RI

Bristol-Myers Squibb Company Ce

$0.11−$0.02

-16.7%

ZIVO

Zivo Bioscience, Inc.Healthcare

$3.01−$0.59

-16.4%

NASDAQ · Mkt cap $17 M

No news headlines were found in the last 48 hours, so the 16.39% drop cannot be attributed to a specific announced catalyst; the decline likely reflects either technical selling, sector headwinds affecting small-cap biotech, or undisclosed company developments.

Zivo Bioscience is a small-cap biotech firm, and the absence of recent news headlines makes direct attribution difficult. However, this category of stock typically experiences sharp daily moves from several sources: clinical trial results or setbacks, FDA decisions on product candidates, capital raise announcements (which dilute shareholders), analyst downgrades, broader biotech sector weakness, or short-term technical/momentum shifts. Given that Zivo ranks as the 38th biggest loser on the day and lacks supporting headlines, the move may reflect a combination of sector rotation out of small-cap biotech, internal company news that has not yet reached mainstream financial feeds, or algorithmic/technical selling pressure. Without concrete information, pinpointing the specific cause remains speculative.

DYN

Dyne Therapeutics IncHealthcare

$20.31−$3.96

-16.3%

NASDAQ · Mkt cap $4.7 B

DYN plunged 16% following Novartis's failed Phase 3 trial for del-desiran in myotonic dystrophy, a key competitive threat to Dyne's own DM1 program, amplifying investor concern about the broader therapeutic space.

The headlines establish that Novartis's del-desiran failed its primary endpoint in the HARBOR Phase 3 study for myotonic dystrophy type 1 on September 8, causing Novartis shares to fall 10%. DYN trades in the same rare disease space and is developing Z-Basivarsen (DYNE-101) for the identical indication. The premarket headline noting a 31% drop with no catalyst confirmed was published at 10:50 UTC, suggesting the market was already pricing in negative implications hours before Novartis officially announced its trial failure. While Dyne's own near-term news was positive (presentation of Phase 1/2 data), the competitive setback in a closely watched indication likely triggered a reassessment of the addressable market and efficacy expectations across the DM1 pipeline. The stock's intraday recovery from the 31% premarket loss to a 16% close suggests some stabilization as investors may have recognized that Dyne's earlier-stage data distinguishes it from Novartis's failed approach.

YSXT

YSX Tech. Co., Ltd Class A Ordinary SharesIndustrials

$1.29−$0.25

-16.2%

NASDAQ · Mkt cap $35 M

No news headlines were published in the last 48 hours, so the 16.23% drop cannot be directly attributed to a disclosed catalyst; this may reflect delayed market reaction to an earlier announcement, technical selling, or market-wide pressure on small-cap stocks.

The absence of recent news makes it impossible to identify a specific catalyst from the information provided. YSXT is a small-cap Chinese ADR trading on NASDAQ, and stocks in this category are often sensitive to broader shifts in sentiment toward Chinese equities, regulatory concerns, liquidity events, or technical factors like moving-average breaks. A single-day drop of this magnitude in a low-priced stock can also reflect algorithmic selling pressure, index rebalancing, or accumulation of negative sentiment from earlier in the week that markets are repricing today. Without a news trigger visible in the RSS feed, the cause remains in the inference category.

ISPC

iSpecimen Inc.Healthcare

$1.58−$0.32

-16.1%

NASDAQ · Mkt cap $3.1 M

No news headlines were found in the last 48 hours, so the 16% drop on September 8 cannot be attributed to a specific announced event. The decline likely reflects broader market weakness, technical selling, or an unannounced development not yet picked up by major news feeds.

iSpecimen Inc. is a small-cap biotech/clinical specimen company, and the absence of news in the immediate 48-hour window before this steep decline makes it difficult to pinpoint a single catalyst. Stocks in this category are typically sensitive to several factors: changes in clinical trial demand or customer announcements that may not immediately appear in mainstream financial news feeds, insider transactions or short reports that circulate via specialist channels before appearing in public headlines, technical breakdown through key support levels that can trigger momentum selling in thinly traded names, or delayed market reaction to older announcements. The 16% single-day loss in a company of this size and market cap often reflects either a liquidity event or a development that has not yet made its way into the tracked news stream.

RENT

Rent the Runway, Inc.

$3.20−$0.61

-16.0%

SGML

Sigma Lithium Corporation

$10.42−$1.98

-16.0%

PAII.WT

Pyrophyte Acquisition Corp. II WT

$0.34−$0.06

-15.7%

GMEX

GMEX ROBOTICS CORPORATION Class ATechnology

$0.63−$0.12

-15.4%

NASDAQ · Mkt cap $1.0 M

No news headlines were found in the last 48 hours to explain GMEX's 15.37% decline, so the driver remains unclear; the drop may reflect sector weakness, technical selling, or an untracked corporate event.

The absence of any news in the Yahoo Finance RSS feed for GMEX over the past 48 hours means we cannot attribute this move to a specific, publicly announced catalyst such as earnings, guidance, a contract win or loss, regulatory action, or M&A activity. For a small-cap robotics company trading at $0.63, possible explanations include broad sector rotation away from robotics or automation stocks, profit-taking or technical break below a support level, a delayed filing or announcement not yet indexed by major news aggregators, insider selling, or increased short pressure. Without corroborating headlines or structural context about GMEX's capital structure or trading characteristics, the actual cause cannot be determined from the available evidence.

NRSN

NeuroSense Therapeutics Ltd.Healthcare

$0.44−$0.08

-15.2%

NASDAQ · Mkt cap $14 M

No news headlines were found in the last 48 hours, so the 15.2% drop cannot be directly attributed to a specific disclosed event. Biotech and small-cap stocks like NRSN are prone to sharp moves on low volume, technical selling, or undisclosed developments.

NeuroSense is a micro-cap biotech company with limited liquidity, and no material news was available in the Yahoo Finance RSS feed during the relevant period. This does not mean no catalyst exists—it may simply mean the trigger was not widely syndicated or the move preceded any formal announcement. Small-cap therapeutics stocks typically respond sharply to clinical trial updates, regulatory decisions, financing announcements, or management changes. The 15.2% single-day decline could reflect profit-taking after a prior rally, sector-wide biotech weakness, or a private development not yet in public circulation. Without headline evidence, the precise driver remains unknown.

GPRO

GoPro IncTechnology

$1.46−$0.26

-15.1%

NASDAQ · Mkt cap $117 M

GoPro surged 40% on September 1 after announcing a merger with Starman Optical to pivot into AI data center optical transceivers, but the stock reversed sharply on September 8, losing 15% as investors likely reassessed the deal or encountered new concerns about execution or valuation.

The headline establishes that GoPro announced a definitive merger with Starman Optical on September 1, which initially drove a 40% rally as the market rewarded the strategic pivot from action cameras to the higher-growth AI data center optical transceiver market. However, the stock has now fallen 15% from that peak, closing at $1.46 on September 8. The provided headlines do not contain news dated after September 1, so we do not have explicit information about what triggered the reversal. Reasonable explanations could include investor doubt about GoPro's ability to execute in a capital-intensive, competitive photonics sector; concerns about the merger terms or valuation as details emerged; profit-taking after the euphoric initial jump; or unrelated market weakness in semiconductor or optical equipment stocks. Without additional reporting dated September 2-8, the exact catalyst remains unclear.

ZOOZ

ZOOZ Power Ltd. Ordinary Shares

$6.95−$1.22

-14.9%

SKYH.WT

Sky Harbour Group Corporation

$0.23−$0.04

-14.8%

IPEX

Inflection Point Acquisition Corp.

$8.49−$1.41

-14.5%